de Zeeuw D - Search Results

1

Albuminuria: what can we expect from the determination of nonimmunoreactive albumin?

Bakker SJ, Gansevoort RT, de Zeeuw D. Bakker SJ, et al. Among authors: de zeeuw d. Curr Hypertens Rep. 2009 Apr;11(2):111-7. doi: 10.1007/s11906-009-0021-x. Curr Hypertens Rep. 2009. PMID: 19278600 Review.

2

C-reactive protein is associated with renal function abnormalities in a non-diabetic population.

Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D. Stuveling EM, et al. Among authors: de jong pe, de zeeuw d. Kidney Int. 2003 Feb;63(2):654-61. doi: 10.1046/j.1523-1755.2003.00762.x. Kidney Int. 2003. PMID: 12631131 Free article.

3

C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease.

Stuveling EM, Hillege HL, Bakker SJ, Asselbergs FW, de Jong PE, Gans RO, de Zeeuw D; PREVEND study group. Stuveling EM, et al. Among authors: de jong pe, de zeeuw d. Atherosclerosis. 2004 Jan;172(1):107-14. doi: 10.1016/s0021-9150(03)00252-1. Atherosclerosis. 2004. PMID: 14709363

4

C-reactive protein modifies the relationship between blood pressure and microalbuminuria.

Stuveling EM, Bakker SJ, Hillege HL, Burgerhof JG, de Jong PE, Gans RO, de Zeeuw D; PREVEND Study Group. Stuveling EM, et al. Among authors: de jong pe, de zeeuw d. Hypertension. 2004 Apr;43(4):791-6. doi: 10.1161/01.HYP.0000120125.08867.42. Epub 2004 Feb 16. Hypertension. 2004. PMID: 14967837

5

Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function.

Verhave JC, Gansevoort RT, Hillege HL, De Zeeuw D, Curhan GC, De Jong PE. Verhave JC, et al. Among authors: de jong pe, de zeeuw d. J Am Soc Nephrol. 2004 May;15(5):1316-22. J Am Soc Nephrol. 2004. PMID: 15100372

6

An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population.

Verhave JC, Gansevoort RT, Hillege HL, Bakker SJ, De Zeeuw D, de Jong PE; PREVEND Study Group. Verhave JC, et al. Among authors: de jong pe, de zeeuw d. Kidney Int Suppl. 2004 Nov;(92):S18-21. doi: 10.1111/j.1523-1755.2004.09205.x. Kidney Int Suppl. 2004. PMID: 15485409 Review.

7

Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment?

de Zeeuw D. de Zeeuw D. Kidney Int Suppl. 2004 Nov;(92):S2-6. doi: 10.1111/j.1523-1755.2004.09201.x. Kidney Int Suppl. 2004. PMID: 15485410 Review.

8

Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC.

Brinkman JW, Bakker SJ, Gansevoort RT, Hillege HL, Kema IP, Gans RO, de Jong PE, de Zeeuw D. Brinkman JW, et al. Among authors: de jong pe, de zeeuw d. Kidney Int Suppl. 2004 Nov;(92):S69-75. doi: 10.1111/j.1523-1755.2004.09219.x. Kidney Int Suppl. 2004. PMID: 15485424 Free article. Review.

9

Trends in the incidence of treated end-stage renal failure in The Netherlands: hope for the future?

Gansevoort RT, van der Heij B, Stegeman CA, de Charro FT, Nieuwenhuizen MG, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Among authors: de charro ft, de jong pe, de zeeuw d. Kidney Int Suppl. 2004 Nov;(92):S7-10. doi: 10.1111/j.1523-1755.2004.09202.x. Kidney Int Suppl. 2004. PMID: 15485425 Review.

10

Should albuminuria be a therapeutic target in patients with hypertension and diabetes?

de Zeeuw D. de Zeeuw D. Am J Hypertens. 2004 Nov;17(11 Pt 2):11S-15S; quiz A2-4. doi: 10.1016/j.amjhyper.2004.08.005. Am J Hypertens. 2004. PMID: 15539105 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters